• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭的体外技术。

Extracorporeal Techniques in Kidney Failure.

机构信息

Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

Department of Nephrology, UZ Leuven, Leuven, Belgium.

出版信息

Blood Purif. 2024;53(5):343-357. doi: 10.1159/000533258. Epub 2023 Sep 12.

DOI:10.1159/000533258
PMID:38109873
Abstract

During the last decades, various strategies have been optimized to enhance clearance of a variable spectrum of retained molecules to ensure hemodynamic tolerance to fluid removal and improve long-term survival in patients affected by kidney failure. Treatment effects are the result of the interaction of individual patient characteristics with device characteristics and treatment prescription. Historically, the nephrology community aimed to provide adequate treatment, along with the best possible quality of life and outcomes. In this article, we analyzed blood purification techniques that have been developed with their different characteristics.

摘要

在过去的几十年中,已经优化了各种策略以增强对各种保留分子的清除能力,以确保在患有肾衰竭的患者中能够耐受液体去除并改善长期生存。治疗效果是患者个体特征与设备特征和治疗方案相互作用的结果。从历史上看,肾脏病学领域的目标是提供足够的治疗,同时获得尽可能好的生活质量和结果。在本文中,我们分析了具有不同特性的已开发的血液净化技术。

相似文献

1
Extracorporeal Techniques in Kidney Failure.肾衰竭的体外技术。
Blood Purif. 2024;53(5):343-357. doi: 10.1159/000533258. Epub 2023 Sep 12.
2
[Does continuous veno-venous hemodiafiltration therapy reduce mortality due to acute renal failure as compared to intermittent hemodialysis?].与间歇性血液透析相比,持续静脉-静脉血液透析滤过疗法是否能降低急性肾衰竭导致的死亡率?
Nefrologia. 2007;27 Suppl 1:42-8.
3
Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.血液透析、血液滤过和无醋酸盐生物滤过治疗终末期肾病的比较:系统评价
Am J Kidney Dis. 2005 Mar;45(3):437-47. doi: 10.1053/j.ajkd.2004.11.008.
4
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.血液透析滤过、血液滤过及血液透析用于终末期肾病
Cochrane Database Syst Rev. 2006 Oct 18(4):CD006258. doi: 10.1002/14651858.CD006258.
5
Proceedings of the 2022 UAB CRRT Academy: Non-Invasive Hemodynamic Monitoring to Guide Fluid Removal with CRRT and Proliferation of Extracorporeal Blood Purification Devices.2022年UAB连续性肾脏替代治疗学会会议论文集:无创血流动力学监测指导连续性肾脏替代治疗中的液体清除及体外血液净化设备的发展
Blood Purif. 2023;52(11-12):857-879. doi: 10.1159/000533573. Epub 2023 Sep 22.
6
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
7
Choice of extracorporeal dialysis modality: can it be evidence based?
Minerva Urol Nefrol. 2007 Sep;59(3):261-7.
8
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
The Infant KIdney Dialysis and Utrafiltration (I-KID) Study: A Stepped-Wedge Cluster-Randomized Study in Infants, Comparing Peritoneal Dialysis, Continuous Venovenous Hemofiltration, and Newcastle Infant Dialysis Ultrafiltration System, a Novel Infant Hemodialysis Device.婴儿肾脏透析与超滤(I-KID)研究:一项针对婴儿的阶梯楔形整群随机研究,比较腹膜透析、连续性静脉-静脉血液滤过以及新型婴儿血液透析设备纽卡斯尔婴儿透析超滤系统。
Pediatr Crit Care Med. 2023 Jul 1;24(7):604-613. doi: 10.1097/PCC.0000000000003220. Epub 2023 Mar 9.
10
Comparing Clearances of Polymethylmethacrylate and Polysulfone Dialyzer Membranes for Postdilution Hemodiafiltration in Patients With Kidney Failure: Protocol for a Systematic Review and Meta-Analysis.比较聚甲基丙烯酸甲酯和聚砜透析器膜在肾衰竭患者后稀释血液透析滤过中的清除率:系统评价与Meta分析方案
JMIR Res Protoc. 2025 Jun 26;14:e71943. doi: 10.2196/71943.

引用本文的文献

1
Comparative Efficacy of pHA130 Haemoadsorption Combined with Haemodialysis Versus Online Haemodiafiltration in Removing Protein-Bound and Middle-Molecular-Weight Uraemic Toxins: A Randomized Controlled Trial.pHA130血液吸附联合血液透析与在线血液透析滤过清除蛋白结合及中分子量尿毒症毒素的疗效比较:一项随机对照试验
Toxins (Basel). 2025 Aug 5;17(8):392. doi: 10.3390/toxins17080392.
2
Haemodiafiltration versus high-flux haemodialysis-a Consensus Statement from the EuDial Working Group of the ERA.血液透析滤过与高通量血液透析——欧洲肾脏协会(ERA)EuDial工作组的共识声明
Nephrol Dial Transplant. 2025 Aug 1;40(8):1590-1614. doi: 10.1093/ndt/gfaf024.
3
Middle Molecular Uremic Toxin and Blood Purification Therapy.
中分子尿毒症毒素与血液净化疗法
J Clin Med. 2024 Jan 23;13(3):647. doi: 10.3390/jcm13030647.